← Back to Search

Fecal ostomy surgery participants receiving the CI-oSurg for Surgery (CI-oSurg Trial)

N/A
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 4 weeks after intervention
Awards & highlights

CI-oSurg Trial Summary

This trial will test a new communication program for people undergoing fecal ostomy surgery. They will include 24 patients and 4 clinicians to see if the program is helpful. They will focus on patients

Who is the study for?
This trial is for adults over 18 who speak and read English fluently, and are about to have elective fecal ostomy surgery. It focuses on understanding the needs of these patients, especially those aged 65 or older.Check my eligibility
What is being tested?
The study tests a communication intervention designed for patients undergoing fecal ostomy surgery. The goal is to see if this approach helps with their recovery process. Participants will answer questionnaires at the start and four weeks after trying the intervention.See study design
What are the potential side effects?
Since this trial involves a communication strategy rather than medication, traditional side effects like you'd expect from drugs aren't applicable here.

CI-oSurg Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 4 weeks after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 4 weeks after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Acceptability
Secondary outcome measures
Intervention Usability
Other outcome measures
Client Satisfaction Questionnaire
Emotional Distress
Hospital Anxiety and Depression Scale
+2 more

CI-oSurg Trial Design

1Treatment groups
Experimental Treatment
Group I: Fecal ostomy surgery participants receiving the CI-oSurgExperimental Treatment1 Intervention
This arm will include patients who are undergoing or have undergone fecal ostomy surgery and surgical clinicians caring for the patients who will receive the CI-oSurg intervention.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,935 Previous Clinical Trials
13,198,613 Total Patients Enrolled
6 Trials studying Surgery
186,916 Patients Enrolled for Surgery

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participant enrollment for this research investigation?

"Indeed, the details on clinicaltrials.gov affirm that recruitment is ongoing for this trial. The study was initially listed on March 18, 2024, and last modified on March 27, 2024. They aim to recruit a total of 28 participants from a single site."

Answered by AI

Are there still opportunities for patients to participate in this ongoing research study?

"Indeed, records from clinicaltrials.gov highlight that this investigation is presently seeking participants. The trial was initially disclosed on March 18th, 2024, and its most recent update was on March 27th, 2024. They aim to enroll a total of 28 patients across one designated site."

Answered by AI
~19 spots leftby Jul 2024